Clinical Trial Update: Safety and Efficacy Trial to Treat Open-Angle Glaucoma or Ocular Hypertension [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update from Santen Inc. describes a safety and efficacy study in Phase 1/2 for open-angle glaucoma and ocular hypertension that has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Snippet

Sponsor: Santen Inc. | Conditions: Open-angle Glaucoma, Ocular Hypertension | Phase 1, Phase 2 | Status: COMPLETED